Stay updated on Chemorad vs Immunorad for Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Chemorad vs Immunorad for Head and Neck Cancer Clinical Trial page.

Latest updates to the Chemorad vs Immunorad for Head and Neck Cancer Clinical Trial page
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedIn the Study Record Dates section, the label changed from 'Last Update Posted (Estimated)' to 'Last Update Posted'; the displayed date value remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check22 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. No trial content, dosing, eligibility, or outcomes were changed.SummaryDifference0.0%

- Check44 days agoChange DetectedAdded a consolidated Locations section listing study sites in AZ, CA, FL, MO, OH, and TN and updated the page revision to v3.3.3. Removed the separate per-state Location entries and the HHS Vulnerability Disclosure link, and deprecated v3.3.2.SummaryDifference0.7%

- Check72 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed from the revision history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange Detected- The notice about government funding and operating status at the top of the ClinialTrials.gov page was removed. - To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check95 days agoChange DetectedThere are no substantive edits to the study record; core details such as title, conditions, endpoints, eligibility criteria, locations, and enrollment remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Chemorad vs Immunorad for Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemorad vs Immunorad for Head and Neck Cancer Clinical Trial page.